Quick Takeaways
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL).
- Disclosed ownership: 6.4%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Soleus Capital Master Fund, L.P. disclosed 6.4% ownership in RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Group, LLC | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus GP LLC | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 6.4% | 1,130,679 | 0 | 1,130,679 | /s/ Guy Levy | Guy Levy |